Enhanced Vancomycin Hemodialysis model now available in DoseMeRx!Learn more →

News & Media

DoseMe to Showcase Precision Dosing Decision Support at Cerner Health Conference

In this article:

DoseMe – the world’s first company to design a precision dosing platform for clinical use – will attend and exhibit at the Cerner Health Conference (CHC) October 9-12 in Kansas City, and has been invited to showcase DoseMeRx in the Solutions Gallery demonstration environment of Cerner Millennium® electronic health record, utilizing Ignite APIs.

DoseMeRx allows healthcare professionals to dose a patient based on their individual ability to absorb, metabolize, distribute and eliminate a therapeutic drug. When accessed through Cerner, DoseMeRx automatically extracts readily available information such as age, weight, dose administered, renal function and previous response to therapy to quickly and accurately calculate the most effective dose to reach a desired therapeutic target, without any additional data entry.

More than 12,000 health care industry leaders, practitioners and Cerner associates are expected to attend CHC – Cerner’s annual three-day, global healthcare event – showcasing their most innovative and cutting-edge solutions and organizations.

DoseMe Chief Scientific Officer, Robert McLeay, will be available to meet with to discuss DoseMeRx SMART on FHIR Cerner integration. Be sure to see him demonstrate DoseMeRx live in the CHC Solutions Gallery where he will be delivering just the right dose of precision medicine.

Cerner clients can register to attend CHC at: https://www.cerner.com/CHC

DoseMe will be demonstrating at booth #835 and presenting in the Cerner Solutions Gallery.

Want to pre-book a DoseMeRx demonstration?
Drop us an email and we will be in touch to schedule your demonstration.

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.